Efficacy of modafinil on fatigue and excessive daytime sleepiness associated with neurological disorders: a systematic review and meta-analysis.
BACKGROUND: Modafinil is a novel wake-promoting agent approved by the FDA ameliorating excessive daytime sleepiness (EDS) in three disorders: narcolepsy, shift work sleep disorder and obstructive sleep apnea. Existing trials of modafinil for fatigue and EDS associated with neurological disorders pro...
Main Authors: | Ping Sheng, Lijun Hou, Xiang Wang, Xiaowen Wang, Chengguang Huang, Mingkun Yu, Xi Han, Yan Dong |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3849275?pdf=render |
Similar Items
-
Excessive Daytime Sleepiness
by: Yavuz Selvi, et al.
Published: (2016-06-01) -
Cancer-related fatigue presenting with excessive daytime sleepiness
by: Diwakar D Balachandran, et al.
Published: (2017-12-01) -
Sonolência excessiva Excessive daytime sleepiness
by: Lia Rita Azeredo Bittencourt, et al.
Published: (2005-05-01) -
Impact of modafinil add-on with atypical anti-psychotics on excessive daytime drowsiness
by: P Lakshmi Prasuna, et al.
Published: (2015-01-01) -
Prevalence of the excessive daytime sleepiness in Russian Federation
by: A. L. Kalinkin
Published: (2019-01-01)